EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intermittent Tacrolimus Treatment Delays CD8+ Tumor‐Infiltrating Lymphocyte Exhaustion and Enhances PD1 Blockade Therapy in Melanoma‐Bearing Mice

Darong Chen iD, Sisi Feng iD, Zhaolong Chen, Zhisheng Weng, Shu Zhang, Junjin Lin iD, Zili Wang iD

Journal of Immunology Research · 2026

DOI: 10.1155/jimr/8444562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Darong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China,…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Programmed Cell Death 1 Receptor, Tacrolimus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Startup Fund for Scientific Research of Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous antigen exposure initiates the developmental process of CD8+ T cell exhaustion, accompanied by a gradual increase in the expression of inhibitory receptors (IRs). Our previous study conceptualized T cell exhaustion as an over‐activation status induced by chronic antigen stimuli. To intervene in the developmental process of CD8+ T cell exhaustion, we adjusted the over‐activation status by intermittently blocking T cell activation signals with tacrolimus, a T cell activation inhibitor. Melanoma‐bearing mice received intermittent tacrolimus (IT) and/or programmed cell death 1 (PD1) blockade antibody. Exhaustion phenotype of CD8+ tumor‐infiltrating lymphocytes (CD8+TILs) was detected by flow cytometry. The expression levels of IRs (PD1 and CD223), as well as memory markers (Ly108 and CD127), were utilized to demarcate the extent of CD8+TILs exhaustion. Then, tyrosinase‐related protein 2 peptide (Trp2 180–188 ) was used to detect tumor‐specific CD8+ TILs. Furthermore, tumor growth rate and tumor weight were also evaluated. We found that IT and/or PD1 blockade enhanced the infiltration of functional CD8+TILs. The findings demonstrated that both IT therapy and PD1 blockade enhanced the antitumor immunity. Combining IT and PD1 blockade led to a greater reduction in tumor growth rate and tumor weight. IT therapy also improved the response of CD8+TILs to melanoma‐specific Trp2 180–188 peptide. A detailed analysis of the CD8+TILs showed that Ly108 and CD127 reduced dramatically as the expression of PD1 increased. In comparison to PD1 blockade, combined treatment (IT plus PD1 blockade) significantly increased the number of intermediate IRs‐expressing CD8+TILs, while reducing the number of high IRs‐expressing CD8+TILs. These results indicated that combined treatment enhanced the function and decelerated the increase in IRs expression of CD8+TILs, deferring the developmental process of CD8+TILs exhaustion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesProgrammed Cell Death 1 ReceptorTacrolimusMelanomaImmune Checkpoint InhibitorsAnimalsT-Cell ExhaustionMiceLymphocyte ActivationDisease Models, AnimalHumansCell Line, TumorMice, Inbred C57BLFemale

Stichwörter der Autor:innen

PD1 blockadeT cell exhaustionover-activationtacrolimu

Substanzen

Programmed Cell Death 1 ReceptorTacrolimusPdcd1 protein, mouseImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China, fjmu.edu.cn.
  • Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350026, Fujian, China, fjmu.edu.cn.
  • Fujian Provincial Institutes of Brain Disorders and Brain Sciences, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China, fjmu.edu.cn.
  • Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China, fjmu.edu.cn.
  • Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350004, Fujian, China, fjmu.edu.cn.
  • Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350026, Fujian, China, fjmu.edu.cn.

ORCID-Profile: Darong Chen, Sisi Feng, Junjin Lin, Zili Wang

Förderung

  • Natural Science Foundation of Fujian Province
  • Startup Fund for Scientific Research of Fujian Medical University

Zitieren

APA

Chen, D., Feng, S., Chen, Z., Weng, Z., Zhang, S., Lin, J., & Wang, Z. (2026). Intermittent Tacrolimus Treatment Delays CD8+ Tumor‐Infiltrating Lymphocyte Exhaustion and Enhances PD1 Blockade Therapy in Melanoma‐Bearing Mice. Journal of Immunology Research. https://doi.org/10.1155/jimr/8444562

Vancouver

Chen D, Feng S, Chen Z, Weng Z, Zhang S, Lin J, et al. Intermittent Tacrolimus Treatment Delays CD8+ Tumor‐Infiltrating Lymphocyte Exhaustion and Enhances PD1 Blockade Therapy in Melanoma‐Bearing Mice. Journal of Immunology Research. 2026. doi:10.1155/jimr/8444562

BibTeX
@article{Chen2026,
  author = {Chen, Darong and Feng, Sisi and Chen, Zhaolong and Weng, Zhisheng and Zhang, Shu and Lin, Junjin and Wang, Zili},
  title = {Intermittent Tacrolimus Treatment Delays CD8+ Tumor‐Infiltrating Lymphocyte Exhaustion and Enhances PD1 Blockade Therapy in Melanoma‐Bearing Mice},
  journal = {Journal of Immunology Research},
  year = {2026},
  doi = {10.1155/jimr/8444562}
}
Kostenlos starten →